Quarterly Report • May 14, 2025
Quarterly Report
Open in ViewerOpens in native device viewer

1
Interim Report Jan – Mar 2025 Precise Biometrics AB (publ), corp. ID no. 556545-6596
Interim Report Jan–Mar 2025
Q1
2

Precise Biometrics (Precise) is a global pioneer in the field of cybersecurity and biometric solutions. The offering includes algorithm products for fingerprint, facial and hand recognition, as well as turn key products for biometric access (Precise Access) and visitor management (Precise Visit by EastCoast).
The focus areas are biometric authentication for mobile phones, laptops, security keys and smart locks, vehicle applications for in-car payment, driver authentication and personal settings/access – as well as specialized systems for visitor management and physical biometric access. Precise operates through two main business areas, Digital Identity and Biometric Technologies, and operates from its offices in Lund (HQ), Stockholm, Potsdam NY, Seoul, Taipei and Shanghai. The Precise share is listed on the Nasdaq Stockholm (PREC). Find out more at www.precisebiometrics.com.
Interim Report Jan – Mar 2025 Precise Biometrics AB (publ), corp. ID no. 556545-6596
| The period in brief |
4 |
|---|---|
| Presentation and Q&A | 5 |
| CEO comments | 6 |
| Security expert Åsa Schwarz on digital threats and cybersecurity | 8 |
| Update from the business areas | 9 |
| Customer offering10 | |
| Net sales and operating profit/loss11 | |
| Consolidated income statement – in summary14 |
|
| Consolidated balance sheet – in summary15 |
|
| Consolidated cash flow statement – in summary 16 |
|
| Consolidated change in equity – in summary17 |
|
| Notes18 | |
| Parent company income statement – in summary21 |
|
| Parent company balance sheet – in summary 22 |
|
| Consolidated key indicators23 | |
| Alternative consolidated key indicators 24 |
|
| Analysis of results, in summary25 | |
| Financial glossary 26 |

(the bullet list below contains links to the relevant press releases)
(the bullet list below contains links to the relevant press releases)
▪ Rebranding initiative to clarify and strengthen Precise's offering
| 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|
| Amounts in SEK thousands unless otherw ise stated | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Net sales | 20 007 | 21 684 | 86 852 | 85 175 |
| Net sales grow th, % | -7,7% | 13,2% | 15,7% | 9,8% |
| EBITDA | -1 689 | 3 069 | 13 379 | 8 622 |
| Gross margin, % | 71,9% | 72,2% | 72,6% | 72,6% |
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 639 |
| Operating margin, % | -35,2% | -13,0% | -10,8% | -16,0% |
| Cash flow from the operating activities | 2 103 | -2 832 | 10 055 | 14 990 |
| Cash and cash equivalents | 36 036 | 41 148 | 37 704 | |
| Annual Recurring Revenue | 18 376 | 18 317 | 18 980 |
See the Financial Glossary for definitions.
Precise has published a video interview with CEO Joakim Nydemark in connection with this report. The interview is designed to complement the report and provide additional depth and a better understanding of the stock market for the company's business operations.
The video is available on the Investor Relations page: https://precisebiometrics.com/sv/investerare/
The company also invites you to a Q&A session. More information and a link to the Q&A session may be found on the Investor Relations page:https://precisebiometrics.com/sv/investerare/
Time of Q&A: May 14, 2025, at 13:00 (CET).
Questions can be asked directly during the Q&A or submitted in advance to [email protected]

We are continuing our journey at a high tempo, even though the figures for the first quarter are affected by quarterly fluctuations and the turbulent global market situation. Net sales for the quarter totaled SEK 20.0 (21.7) million and EBITDA was SEK -1.7 (3.1) million. Both net sales and earnings are affected by the weakening US dollar and a change in the allocation of revenue from a customer agreement. The latter affects the quarter, but not the full year. EBITDA adjusted for these two factors totals SEK 0.9 million, which is in line with our expectations given the cost of increasing our selling power and the caution we are experiencing among our customers linked to the uncertainty surrounding the effects of new tariffs. At the same time, cash flow of SEK 2.1 million (-2.8) represents an improvement compared to the corresponding quarter last year. There has also been commercial progress during the period, including in national ID programs where we have been approved by the Unique Identification Authority of India (UIDAI) for use in Aadhaar, the national ID program. We feel that demand for the company's products is increasing, even though the market situation is prolonging business discussions, and given the new customer projects initiated during the quarter, we have a positive view of the full year 2025. We are continuing to execute on the commercialization strategy and growth journey that has only just begun.
We are well-positioned to continue to deliver market-leading visitor management systems, security solutions and biometric products with a focus on expansive verticals and geographies. We are cost-conscious, and by renegotiating supplier agreements and efficiency improvements, we have been able to increase our selling power and productivity with a relatively small cost increase. This will yield results during 2025.
The first quarter was characterized by new mobile projects and intensive work aimed at customers and partners both within the mobile vertical and for our latest offerings linked to hand recognition and anti-spoofing for national ID programs. By meeting the strict requirements of national ID programs such as Aadhaar, BioLive not only boosts the integrity of these systems, but also sets a new standard for anti-spoofing and liveness detection, opening up new geographical markets such as Southeast Asia, Africa, and South America.
Sensor production, which governs our royalty volumes, can also vary greatly between different quarters, which is why it is important to view the company's growth over a number quarters, not just individual quarters. Given the turbulent global situation, volumes have varied more than usual, as many of our customers have been more cautious in their production during the past quarter – in order to avoid high inventory levels if sales of consumer products were to be negatively affected by tariffs or the economic climate in general. We feel confident in our relationship with partners and remain optimistic about growth for 2025. With end products in several verticals and in Asia, Europe, and the USA, we have good coverage, which we believe will balance the volumes over time.
The vehicle vertical has now started to deliver royalty volumes, and despite the market situation, this segment came in slightly higher than expected in the first quarter. The trend is increasing continuing towards the Software Defined Vehicle (SDV) concept, where we are positioning ourselves together with Infineon as a world leader in the field of biometrics for the automotive industry.
Growth in our offerings in the Digital Identity business area is still not at the level we want to be, but it is now moving forward and we can see that our framework agreements with larger companies will contribute to positive development going forward. During the quarter, we made investments and launched new products, such as a locally installed (on-premise) version of Precise Access, our physical access solution, as a complement to the company's existing hybrid cloud solution. By offering full on-premise implementation, we are meeting the increasingly demanding security requirements of high-security organizations including government agencies, critical infrastructure facilities, and defense organizations.
During the quarter, we further strengthened the sales organization by hiring sales resources in Norway. These will be working closely with the Swedish organization to ensure rapid upscaling and cost efficiency. The goal is to both accelerate business with customers and build a local partner network. We see a growing demand for our visitor management system, both in Sweden and internationally, which, combined with the fact that many existing customers are expanding the solution to more offices, creates the conditions for growth in 2025.

The continued migration to the cloud is one of the highlights of the period, with
customers who migrated including Alfa Laval, Familjebostäder, Tobii Technology and Öresundskraft. Demand continues to benefit from several external factors, such as the security situation, new regulatory requirements and the fact that modern companies want to be more customer-centric.
To further enhance and clarify our offering, and to simplify internal processes, we are bringing all products together under the Precise brand. The name YOUNiQ is disappearing and EastCoast will become part of the Precise Visit name. Our physical access system will be called Precise Access and our visitor management system Precise Visit by EastCoast. Company names are not affected, nor the product functionality.
There is an incredible level of activity in the areas that are the cornerstones of our business – biometrics, cybersecurity, seamless access and AI. In parallel with our commercialization strategy, we are continuing to open up new offerings, including national ID programs, hand recognition and on-premise access systems.
I feel that we have an extremely positive and exciting future ahead of us, and if I look ahead to the coming year, there is a lot to suggest healthy growth. In a society where security and user-friendliness are becoming increasingly central, our solutions help create greater peace of mind. As one of the actors in the field of ultrasound algorithms, I see potential for increased revenue, while we make progress in cybersecurity, the automotive industry and biometric solutions for government agency projects. With a strong product portfolio, stable finances and long-term partnerships, we are well positioned.
Many thanks to our highly competent team, customers and partners. Together we are creating a simpler and safer world. Onwards and upwards!
Joakim Nydemark CEO

In a world where digital threats are becoming increasingly sophisticated, cybersecurity is more important than ever. Åsa Schwarz, expert on the subject and Board member at Precise, shares her thoughts on today's biggest risks, how companies and individuals can protect themselves – and how she combines cybersecurity with her work as an author.
I started programming as a child, but came into contact with cybersecurity during a summer course while studying at university. Then I was hooked.
Cybersecurity nowadays is a broad concept meaning that you work systematically to ensure that information in systems and networks is available, correct, and can only be accessed by the right people. The big difference today is that all businesses are completely dependent on IT, which makes security and secure systems even more important now than ever before.
In the past it was detached, but now the two are very much interlinked. Our locks and alarms are digitalized, and it's every bit as important that the bolt in a lock is as robust as the IT system behind it. If you have biometric solutions such as those from Precise, it's even more integrated.
Hackers try to gain access to either money or information, and we see that in some countries criminal hacker groups collaborate with state actors. It makes a big difference whether you're a private individual or a company. Private individuals are often targeted by fraud and phishing. Companies often have a much broader risk profile, facing everything from ransomware, where a criminal encrypts your information and hard drives, DDoS attacks, where systems become unavailable, to problems with suppliers who have security problems themselves. And we mustn't forget that many incidents are due to user error or poor systems.
As a private individual, you can keep in mind some basic measures such as always having backup, multi-factor authentication and long passwords.
But above all, you must be alert when things are not as they usually are. Companies need to work systematically with cybersecurity throughout the organization.
One of the biggest preconceptions is that it's the IT department's problem. Many breaches and errors are caused by users making mistakes. Management and, in some cases, the Board of Directors must also be involved in determining the risk appetite and focus of security work.
Precise has several different solutions that increase security while making life a little easier for users. One typical example is fingerprints to open a mobile phone, computer or car. Support for visitor management is also an important part of a company's systematic security work.
Right now, the world around us is extremely turbulent, which means that companies must find ways to continuously manage new risks. Criminal activity online has also increased significantly, which increases the need for security.
That's the classic question. I think we'll continue as before, with the villains constantly challenging and finding new ways, while those of us working with security are constantly learning and improving. The big trend is that those that are good at managing incidents are also the ones that perform the best.
Although all my books are thrillers, some also deal with cybersecurity. For example, Master of Dolls has elements of artificial intelligence and security, and The Seven Keys is a hacker thriller.
Interim Report Jan – Mar 2025 Precise Biometrics AB (publ), corp. ID no. 556545-6596 Åsa Schwarz Board member at Precise Biometrics and Enea, and Head of Business Development at Knowit Cybersecurity & Law. She also writes thrillers.
The market for the company's biometric platform suite continues to grow, and Precise continues to hold a very strong position, primarily in the ultrasonic and anti-spoof segment. The market for our customers' sensor hardware is competitive and under price pressure, but the algorithm software for ultrasonic and anti-spoof has better margins.
Precise is constantly taking new steps in terms of functionality and performance in its biometric platform suite. One specific example is the new packaging of the BioLive anti-spoof solution, where both AI technology and services in the form of data collection are important components.
Precise has a strong offering in the field of visitor management systems and physical access. The company grows its customer base through both new customers and additional sales to existing customers.
The offering for the Precise Visit by EastCoast visitor management system (formerly EastCoast Visit in Sweden and YOUNiQ Visit internationally) is growing and expanding internationally, while also being enhanced with new functionality.
The first month of the year was weak, which is normal, but towards the end of the period there was strong growth, and during the quarter new and updated agreements were signed with, among others, Atlas Copco, Certego Norge, the City of Helsingborg, Norstedts, SJ Stockholms Tåg and Tradera. The company has also seen its solutions implemented in new geographical markets such as Germany and Latvia.
The visitor management system initiative is being affected in the short term by higher churn, as a result of the change in strategy that involved an investment in a scalable cloud and SaaS solution. Some customers with legacy on-premise solutions are choosing not to renew their agreements. The main reason is that they no longer see any need for a visitor management system. A small number of customers also requesting special functionality that is not available in the cloud solution. Even if this means a temporary cut in the ARR stock, Precise and its management are convinced that building a more uniform and scalable cloud business is the right decision in the medium to long term. Management also believes that this negative impact will be short-term. Evidence of this is provided by strong new sales of our cloud solution, the fact that no cloud customers left during the quarter and the positive trend that can be seen in connection with framework agreements with large corporate groups.
Sales of Precise Access did not meet expectations during the quarter, mainly due to economic uncertainty in the world at large and uncertainty about GDPR and similar regulations. But interest in the solution remains greater than ever, given the situation in the world and the opportunities offered by the product. There has been a particularly high level of interest in hand modality, which was evident at the ISC West security trade event in Las Vegas. The product was on display at the Genetec booth during the event.
Several new functions have been launched, including Agreement Signature, where links can be created between the visitor management system and confidentiality agreements.
Interim Report Jan – Mar 2025
In a society where security and user-friendliness are becoming increasingly central, Precise helps create increased peace of mind by developing innovative technical solutions in the areas of cybersecurity and biometric recognition. Simplicity and a first-class user experience are combined with performance and a high level of security. Instead of using a PIN, password, key, card, etc. you use your finger, face or hand for authentication or identification.
There are areas of application in both digital and physical access, and the applications are found in, for example, mobile phones, laptops, logical access, payment, vehicles, and in visitor management and access systems, and various forms of government initiatives such as national ID systems and Automated Biometric Identification Systems (ABIS).
The offering consists of biometric algorithm products, basic technology, which component manufacturers use in their products, and also end-customer products for access and visitor management.
The focus is on creating a safe and seamless everyday environment for people by combining user-friendliness with a high level of security in our cybersecurity and biometric security solutions.
▪ Unique knowledge, as biometrics and cybersecurity has been the company's core business for 25 years.

Net sales during the quarter totaled SEK 20.0 (21.7) million, divided between royalty revenues of SEK 8.7 (10.5) million, license fees (including support and maintenance) of SEK 9.8 (9.8) million and other revenues of SEK 1.5 (1.4) million. Royalty revenues during the first quarter are slightly lower than in the previous year, which is partly explained by a renegotiated customer agreement. The agreement entails increased revenue on an annual basis, but lower royalty revenue in Q1 by approximately SEK 1 million. The agreement will have a positive effect in the second half of the year, as revenues will be distributed more evenly between the quarters ahead. A weaker USD also had a negative impact on royalty revenues.
Net sales for Biometric Technologies totaled SEK 14.9 (16.7) million and are reported under royalties at SEK 8.7 (10.5) million, licenses at SEK 5.1 (5.3) million, and other revenue at SEK 1.1 (0.9) million. Royalty revenues in the first quarter were slightly lower than in the previous year, as a consequence of a renegotiated customer agreement and a weaker USD. The renegotiation of the agreement is positive and entails an increase in revenue on an annual basis, but the change affects how revenue is distributed over the year. The gross margin during the quarter totaled 82.9% (85.3). The decrease is mainly due to lower net sales. Royalty revenues are based on customers' sales volumes, and a reduction in royalty revenues therefore has a negative impact on margins as they do not entail lower costs.
Net sales for Digital Identity totaled SEK 5.1 (5.0) million and are reported under licenses at SEK 4.7 (4.5) million, and other revenue at SEK 0.4 (0.5) million.
The proportion of annual recurring revenue (ARR) was SEK 18.4 (18.3) million at the end of the quarter.

The gross margin during the quarter totaled 71.9% (72.2). The decrease is primarily due to lower royalty revenues. Amortization of capitalized development expenses totaled SEK 3.9 (4.3) million. Amortization of acquired intangible assets totaled SEK 0.6 (0.6) million.
Operating expenses for the quarter increased to SEK 21.4 (18.5) million. During the quarter, the company was negatively affected by the USD exchange rate, which in its entirety resulted in other operating expenses of SEK -1.6 million. The corresponding period in the previous year saw operating income of SEK 0.7 million, which means a currency-related change of SEK 2.3 million between the periods. Personnel expenses increased slightly during the quarter due to more employees, but the company also reduced consultancy expenses.
The profit/loss at EBITDA level decreased to SEK -1.7 (3.1) million, which is explained by the exchange rate impact, a renegotiated customer agreement which in accounting terms entails approximately SEK 1 million lower income in the quarter – but higher income on an annual basis – and increased personnel expenses for the sales and product organization.
The operating profit/loss (EBIT) for the quarter totaled SEK -7.1 (-2.8) million. Earnings for the quarter totaled SEK -7.2 (-3.0) million. Total depreciation/amortization of SEK 5.4 (5.9) million.

Earnings per share (average number of shares) for the quarter totaled SEK -0.09 (-0.04).
Interim Report Jan – Mar 2025
Precise Biometrics AB (publ), corp. ID no. 556545-6596
Net financial items for the quarter totaled SEK -0.2 (-0.2) million and the tax expense totaled SEK 0.1 (0.1) million.
Net financial items are attributable to exchange rate differences in cash and cash equivalents, interest income, interest on the lease liability in accordance with IFRS 16, as well as interest expense on the deferred fixed purchase price related to the acquisition of EastCoast.
The cash flow from operating activities during the quarter totaled SEK 2.1 (-2.8) million, of which SEK 4.1 (-5.8) million is attributable to changes in working capital. The Group invested SEK 0.0 (0.0) million in property, plant and equipment during the period. Total cash flow for the period was SEK -1.5 (-6.5) million.
Development expenses of SEK 3.0 (3.0) million were capitalized during the quarter, and amortization of capitalized development expenses in respect of Digital Identity and Biometric Technologies totaled SEK 3.9 (4.3) million.
No new rental agreements were added during the quarter, but an extension of rental agreements in Lund and indexation of rent in Lund and Stockholm resulted in an increase in lease liabilities of SEK 3.4 (5.8) million.
Cash and cash equivalents at the end of the period totaled SEK 36.0 (41.1) million. Total equity at the end of the period was SEK 143.6 (156.5) million, and equity per share was SEK 1.83 (1.99).

The parent company's net sales for the quarter totaled SEK 16.1 (17.7) million and operating profit/loss for the quarter totaled SEK -6.8 (-3.1) million and was charged with amortization of goodwill totaling SEK 0.6 (0.6) million. Cash and cash equivalents at the end of the interim period totaled SEK 23.6 (26.7) million, and equity SEK 132.1 (146.1) million.
The organization consists of the head office in Lund, Sweden, and offices in Stockholm, Sweden, Potsdam, USA, and Shanghai, China. At the end of the interim period, the Group had a workforce of 45 (43) people, including on-site consultants. The number of employees was 36 (32), of which 29 (24) were located in Sweden. Precise works in an agile way together with several partners, creating a fast-moving, scalable organization. The number of employees does not include partners.
The Group and parent company's business risks and risk management as well as the management of financial risks are described in detail in the Annual Report for 2024, which was issued in April 2025. There have been no incidents of significant importance since then that would affect or change these descriptions of the Group or parent company's risks and how they are managed.
Precise Biometrics AB (publ), corporate ID number 556545- 6596, is the parent company in the Precise Biometrics Group. Precise Biometrics AB's shares are listed on the Small Cap list of the Nasdaq OMX Nordic. The number of shareholders at the end of the quarter was 22,299 (16,270). 50,037,551 (13,305,644) PREC shares were traded during the quarter. The closing price on March 31 was SEK 4.01 (1.11), and during the quarter the share price fluctuated between SEK 2.98 (0.80) and SEK 5.77 (1.17).
This interim report has not been audited by the company's auditors.
The undersigned certifies that the interim report provides a true and fair view of the parent company's and the Group's operations, financial position and financial results, and describes the significant risks and uncertainty factors faced by the parent company and the companies that belong to the Group.
Chairman of the Board
| Howard Ro | Peter Gullander | Maria Rydén | Åsa Schwarz |
|---|---|---|---|
| Board member | Board member | Board member | Board member |
Joakim Nydemark
CEO
For further information, please contact: Joakim Nydemark, CEO Email: joakim.ný[email protected]
This information is information that Precise Biometrics AB is obligated to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication on May 14 at 08:00 (CET).
Interim Report Jan – Mar 2025
| 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Net sales | 2,3 | 20 007 | 21 684 | 86 852 | 85 175 |
| Cost of goods sold | -5 615 | -6 027 | -23 786 | -23 374 | |
| Gross profit | 14 392 | 15 657 | 63 066 | 61 801 | |
| Marketing and sales expenses | -8 804 | -8 484 | -32 982 | -33 302 | |
| Administrative expenses | -3 944 | -3 850 | -13 789 | -13 883 | |
| R&D expenses | -7 097 | -6 808 | -26 966 | -27 255 | |
| Other operating income/expenses | -1 597 | 658 | 1 256 | -999 | |
| -21 441 | -18 483 | -72 480 | -75 438 | ||
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 639 | |
| Finacial income/expenses | 4 | -228 | -229 | 630 | 631 |
| Profit/Loss before tax | -7 278 | -3 055 | -8 784 | -13 007 | |
| Tax | 86 | 86 | 351 | 351 | |
| Profit/loss for the period attributable to parent company | |||||
| shareholders | -7 193 | -2 969 | -8 433 | -12 657 | |
| Earnings per share, remaining operations, SEK* | |||||
| - before dilution | -0,09 | -0,04 | -0,11 | -0,16 | |
| - after dilution | -0,09 | -0,04 | -0,11 | -0,16 | |
| CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | |||||
| Profit/Loss for the period | -7 193 | -2 969 | -8 433 | -12 657 | |
| Other comprehensive income: | |||||
| Items that may be reclassified to profit or loss | |||||
| Changes in accumulated exchange rate differences | -342 | 158 | 274 | -226 | |
| Other comprehensive income for the period | -342 | 158 | 274 | -226 | |
| Profit/Loss total attributable to holders of participations in | |||||
| the parent company | -7 535 | -2 811 | -8 159 | -12 883 |
*Dilution effects are only considered in the event that the earnings per share become worse. Dilution effects have not been considered, as the average price is below the subscription price in current option programs.
Interim Report Jan – Mar 2025
Amounts in SEK thousand
| ASSETS | Note | 2025-03-31 | 2024-03-31 | 2024-12-31 |
|---|---|---|---|---|
| FIXED ASSETS | ||||
| Material assets | 13 174 | 11 312 | 10 639 | |
| Goodw ill and immaterial assets | 123 230 | 130 804 | 124 741 | |
| TOTAL FIXED ASSETS | 136 404 | 142 116 | 135 380 | |
| CURRENT ASSETS | ||||
| Inventories | 222 | 292 | 242 | |
| Accounts receivable | 22 748 | 26 845 | 23 813 | |
| Other current receivabels | 2 922 | 3 016 | 3 123 | |
| Accruals and deferred income | 3 184 | 3 056 | 2 804 | |
| Cash and cash equivalents | 4,6 | 36 036 | 41 148 | 37 704 |
| TOTAL CURRENT ASSETS | 65 113 | 74 357 | 67 686 | |
| TOTAL ASSETS | 201 517 | 216 473 | 203 066 | |
| EQUITY AND LIABILITIES | ||||
| EQUITY | ||||
| Equity | 143 629 | 156 509 | 151 163 | |
| TOTAL EQUITY ATTRIBUTABLE TO PARENT COMPANY SHAREHOLDERS | 143 629 | 156 509 | 151 163 | |
| LONG-TERM DEBT | ||||
| Long term debt | 6 | 19 233 | 22 614 | 16 281 |
| TOTAL LONG-TERM DEBT | 19 233 | 22 614 | 16 281 | |
| SHORT-TERM LIABILITIES | ||||
| Short-term liabilities | 4,6 | 38 656 | 37 350 | 35 621 |
| Total Short-term liabilities | 38 656 | 37 350 | 35 621 | |
| TOTAL EQUITY AND LIABILITIES | 201 517 | 216 473 | 203 066 |
| 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Cash flow from operating activities | |||||
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 639 | |
| Adjustments for items not included in cash flow | 5 252 | 6 011 | 22 928 | 22 169 | |
| Interest payments, net | -228 | -229 | 630 | 631 | |
| Tax paid | 3 | - 7 | -22 | -12 | |
| Cash flow from operating activities | -2 024 | 2 949 | 14 122 | 9 149 | |
| before changes in working capital | |||||
| Cash flow from changes in working capital | |||||
| Change in inventories | 20 | 66 | 117 | 71 | |
| Change in current receivables | 824 | -7 306 | -4 113 | 4 017 | |
| Change in current liabilities | 3 283 | 1 459 | -71 | 1 753 | |
| 4 127 | -5 781 | -4 067 | 5 841 | ||
| Cash flow from operating activities | 2 103 | -2 832 | 10 055 | 14 990 | |
| Acquisition of subsidiaries | 6 | 0 | 0 | -6 168 | -6 168 |
| Investment in fixed assets | -40 | 31 | -370 | -441 | |
| Investment in intangible assets | -2 961 | -3 055 | -10 967 | -10 873 | |
| Cash flow from investing activities | -3 001 | -3 024 | -17 505 | -17 482 | |
| New share issue | 0 | 0 | 0 | 0 | |
| Commission expenses | 0 | 0 | 0 | 0 | |
| Repurchase of ow n shares | - 1 | - 1 | - 3 | - 3 | |
| Payment of lease liability | -600 | -622 | -2 542 | -2 520 | |
| Cash flow from financing activities | -601 | -623 | -2 545 | -2 523 | |
| Total Cash flow | -1 498 | -6 478 | -9 994 | -5 014 | |
| Cash & cash equivalents at beginning of year | 37 704 | 47 534 | 47 534 | 41 148 | |
| Exchange rate differences in cash & cash equivalents | -171 | 91 | 164 | -98 | |
| Cash & cash equivalents at end of period 1) | 36 036 | 41 148 | 37 704 | 36 036 |
1) The balance sheet item Cash & Cash Equivalents only includes bank balances at both the beginning and end of the period.
| Amounts in SEK thousand | 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|---|
| Note | Jan - Mar | Jan-Mar | Full-year | 12 mth | |
| Equity at start of period | 151 163 | 159 319 | 159 319 | 156 509 | |
| Comprehensive income | |||||
| Profit/loss for the period | -7 193 | -2 969 | -8 433 | -12 657 | |
| Other comprehensive income | |||||
| Exchange differences | -342 | 158 | 274 | -226 | |
| Total other comprehensive income | -342 | 158 | 274 | -226 | |
| Total comprehensive income | -7 535 | -2 811 | -8 159 | -12 883 | |
| Transactions with shareholders | |||||
| LTI programme | 5 | 1 | 1 | 2 | 2 |
| New share issue | 0 | 0 | 0 | 0 | |
| New issue cost | 0 | 0 | 0 | 0 | |
| Total transactions w ith shareholders | 1 | 1 | 2 | 2 | |
| Equity end of period | 143 629 | 156 509 | 151 163 | 143 629 |
This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting. The parent company's financial statements have been prepared in accordance with the Swedish Annual Accounts Act and the Swedish Annual Reporting Board's recommendation RFR 2, Accounting for Legal Entities. The recognition and measurement policies and bases of estimates applied in the Annual Report for 2024 report have also been used in this interim report.
| 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|
| Amounts in SEK thousand | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Segment | ||||
| Biometric Technologies | ||||
| Royalty | 8 663 | 10 488 | 41 089 | 39 264 |
| Licenses, incl. support & maintenance | 5 121 | 5 281 | 21 976 | 21 816 |
| Other | 1 146 | 911 | 2 358 | 2 593 |
| Digital Identity | ||||
| Licenses, incl. support & maintenance | 4 640 | 4 515 | 18 588 | 18 713 |
| Other | 437 | 489 | 2 841 | 2 789 |
| Total | 20 007 | 21 684 | 86 852 | 85 175 |
| Timing of revenue recognition | ||||
| At point in time* | 10 258 | 11 884 | 47 777 | 46 152 |
| Over time** | 9 749 | 9 800 | 39 075 | 39 023 |
| Total | 20 007 | 21 684 | 86 852 | 85 175 |
| Region/Country | ||||
| Europe | 6 474 | 5 824 | 27 598 | 28 248 |
| - w hereof Sw eden | 5 264 | 4 819 | 20 356 | 20 801 |
| Asia | 6 395 | 8 125 | 29 443 | 27 713 |
| - w hereof China | 275 | 361 | 1 372 | 1 286 |
| - w hereof Taiw an | 5 327 | 6 871 | 24 963 | 23 420 |
| USA | 7 138 | 7 735 | 29 811 | 29 214 |
| Total | 20 007 | 21 684 | 86 852 | 85 175 |
* Sale at a certain time means that revenue is reported point-in-time at the start of the agreement period, when control has been transferred to the customer. Royalties have been moved to sales at a certain point in time in order to provide a more accurate picture.
** Sales over time means that revenue is accrued on a straight-line basis over the term of the agreement.
| 2025 | 2024 | |||||
|---|---|---|---|---|---|---|
| Amounts in SEK thousand | Jan - Mar | Jan - Mar | ||||
| Biometric Technologies |
Digital Identity |
Total Segment |
Biometric Technologies |
Digital Identity |
Total Segment |
|
| Net sales | 14 930 | 5 077 | 20 007 | 16 680 | 5 004 | 21 684 |
| Cost of goods sold exkl. depreciation | -272 | -1 057 | -1 328 | -220 | -1 063 | -1 284 |
| Depreciation included in cost of sold goods | -2 289 | -1 998 | -4 287 | -2 238 | -2 505 | -4 744 |
| Gross profit | 12 370 | 2 022 | 14 392 | 14 221 | 1 435 | 15 657 |
| 2024 | Rolling | |||||
|---|---|---|---|---|---|---|
| Full-year | 12 mth | |||||
| Biometric Technologies |
Digital Identity |
Total Segment |
Biometric Technologies |
Digital Identity |
Total Segment |
|
| Net sales | 65 424 | 21 428 | 86 852 | 63 675 | 21 501 | 85 175 |
| Cost of goods sold exkl. depreciation | -1 259 | -4 297 | -5 556 | -1 310 | -4 290 | -5 600 |
| Depreciation included in cost of sold goods | -9 402 | -8 828 | -18 230 | -9 452 | -8 321 | -17 773 |
| Gross profit | 54 764 | 8 303 | 63 066 | 52 913 | 8 890 | 61 801 |
Only net sales and product costs are allocated to each segment. Other costs are not allocated at segment level as these items relate to group operations
| 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|
| Reconciliation profit/Loss | jan-mar | jan-mar | Full-year | 12 mth |
| Gross profit | 14 392 | 15 657 | 63 066 | 61 801 |
| Marketing and sales expenses | -8 804 | -8 484 | -32 982 | -33 302 |
| Administrative expenses | -3 944 | -3 850 | -13 789 | -13 883 |
| R&D expenses | -7 097 | -6 808 | -26 966 | -27 255 |
| Other operating income/expenses | -1 597 | 658 | 1 256 | -999 |
| Finacial income/expenses | -228 | -229 | 630 | 631 |
| Profit/Loss before tax | -7 278 | -3 055 | -8 784 | -13 007 |
Interim Report Jan – Mar 2025
The fair value in respect of financial assets and liabilities corresponds in all material respects with the carrying amount in the balance sheet.
On November 30, 2022, a supplementary agreement was signed that changed the terms and conditions for the remaining liability of SEK 55,000 thousand for the acquisition of EastCoast Solutions AB (see Note 6). SEK 30,000 thousand was paid on December 1, 2022, SEK 10,000 thousand on November 30, 2023 and SEK 5,000 thousand on November 30, 2024. SEK 5,000 thousand will be paid on November 30, 2025 and SEK 5,000 thousand on November 30, 2026. Interest will be added to the amounts of SEK 5,000 thousand due on November 30, 2025 and SEK 5,000 thousand due on November 30, 2026. Interest for the period from December 1, 2023 to November 30, 2024 was paid on November 30, 2024. The interest, of 3 months STIBOR + 8%, will be added from November 30, 2023 until the amounts have been paid. The liability is recognized as an interest-bearing liability as of March 31, 2025.
The liability has been calculated at current value at the original effective interest rate of 1.8% and is recognized as other current liabilities (SEK 5,961 thousand) and other non-current liabilities (SEK 5,351 thousand).
The Annual General Meeting 2022 resolved, in accordance with the Board's proposal, to establish a long-term share bonus program (LTI 2022/2028) for all employees at Precise Biometrics. In order to facilitate the implementation of LTI 2022/2028 and to ensure the delivery of shares to the participants, and to cover the company's costs for social security contributions, the meeting also decided to amend the Articles of Association in the form of the introduction of new Class C shares, authorization for the Board of Directors to issue Class C shares, authorization for the Board of Directors to buy back Class C shares, and approval of the transfer of shares to participants in LTI 2022/2028. The implementation of Class C shares took place in Q4 2022. As of March 31, 2025, Precise Biometrics held 1,085,000 Class C shares.
As of November 30, 2021, the Group acquired 100% of the shares in EastCoast Solutions AB and Besökssystem Sverige AB.
The purchase price totaled SEK 86,203 thousand, of which SEK 24,466 thousand was paid as at December 31, 2021, partly via a cash payment of SEK 18,000 thousand and partly via the issuing of new shares totaling SEK 6,466 thousand. An additional SEK 8,268 thousand was paid in cash in January 2022.
On November 30, 2022, a supplementary agreement was signed that changed the terms and conditions for the remaining liability of SEK 55,000 thousand for the acquisition. See Note 4 for details of the new terms and conditions.
Impact on cash and cash equivalents in 2025 (reported in investing activities):
There is no impact on the Group's cash and cash equivalents during Q1 2025. See Note 4 regarding repayment of liability.
| 2025 | 2024 | 2024 | Rullande | ||
|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | jan-mar | jan-mar | Helår | 12 mån |
| Net sales | 1 | 16 065 | 17 710 | 69 959 | 68 314 |
| Cost of goods sold | -7 624 | -8 214 | -32 412 | -31 823 | |
| Gross profit | 8 441 | 9 496 | 37 547 | 36 491 | |
| Marketing and sales expenses | -6 414 | -5 684 | -20 783 | -21 513 | |
| Administrative expenses | -3 815 | -3 727 | -13 227 | -13 315 | |
| R&D expenses | -3 381 | -3 803 | -16 031 | -15 609 | |
| Other operating income/expenses | -1 587 | 655 | 1 261 | -981 | |
| -15 197 | -12 559 | -48 780 | -51 418 | ||
| Operating profit/loss | -6 756 | -3 063 | -11 233 | -14 927 | |
| Financial income/expenses | -100 | -140 | 809 | 849 | |
| Group contributions received | 0 | 0 | 151 | 150 | |
| Profit/loss before tax | -6 856 | -3 202 | -10 274 | -13 928 | |
| Tax | 0 | 0 | 0 | 0 | |
| Profit/loss for the period | -6 856 | -3 202 | -10 274 | -13 928 |
Amounts in SEK thousand
| ASSETS | Note | 2025-03-31 | 2024-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Fixed assets | ||||
| Fixed assets | 975 | 1 776 | 1 196 | |
| Immaterial assets | 21 379 | 29 282 | 22 812 | |
| Deferred tax assets | 90 558 | 90 558 | 90 558 | |
| TOTAL FIXED ASSETS | 112 912 | 121 616 | 114 566 | |
| CURRENT ASSETS | ||||
| Inventories | 0 | 64 | 0 | |
| Accounts receivable | 20 791 | 24 467 | 20 859 | |
| Receivable Group | 8 259 | 2 074 | 8 145 | |
| Other receivables | 1 633 | 11 656 | 1 841 | |
| Accruals and deferred income | 2 616 | 2 635 | 2 449 | |
| Cash and cash equivalents | 23 640 | 26 655 | 25 452 | |
| TOTAL CURRENT ASSETS | 56 939 | 67 551 | 58 746 | |
| TOTAL ASSETS | 169 851 | 189 167 | 173 312 | |
| EQUITY AND LIABILITIES | ||||
| Restricted Equity | ||||
| Share capital | 23 539 | 23 539 | 23 539 | |
| Statutory reserve | 1 445 | 1 445 | 1 445 | |
| Reserve for development expenses | 15 272 | 20 002 | 15 911 | |
| Total restricted equity | 40 255 | 44 986 | 40 895 | |
| Unrestricted Equity | ||||
| Share premium reserve | 168 316 | 168 316 | 168 316 | |
| Retained earnings | -69 576 | -64 033 | -59 942 | |
| Profit/loss for the year | -6 857 | -3 203 | -10 274 | |
| Total non-restricted equity | 91 883 | 101 081 | 98 100 | |
| Total Equity | 132 139 | 146 066 | 138 995 | |
| LONG-TERM DEBT | ||||
| Long term debt | 5 350 | 11 351 | 5 337 | |
| TOTAL LONG-TERM DEBT | 5 350 | 11 351 | 5 337 | |
| SHORT-TERM LIABILITIES | ||||
| Short-term liabilities | 32 362 | 31 750 | 28 979 | |
| Total Short-term liabilities | 32 362 | 31 750 | 28 979 | |
| TOTAL EQUITY AND LIABILITIES | 169 851 | 189 167 | 173 312 |
| 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|
| Amounts in SEK thousands unless otherw ise stated | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Net sales | 20 007 | 21 684 | 86 852 | 85 175 |
| Net sales grow th, % | -7,7% | 13,2% | 15,7% | 9,8% |
| Gross margin, % | 71,9% | 72,2% | 72,6% | 72,6% |
| EBITDA | -1 689 | 3 069 | 13 379 | 8 622 |
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 639 |
| Working capital * | 32 417 | 43 135 | 38 019 | 32 417 |
| Capital employed | 154 939 | 173 988 | 162 455 | 154 939 |
| Liquidity ratio, % | 167,9% | 198,3% | 189,3% | 167,9% |
| Equity/assets ratio, % | 71,3% | 72,3% | 74,4% | 71,3% |
| Earnings per share before dilution, SEK | -0,09 | -0,04 | -0,11 | -0,16 |
| Earnings per share after dilution, SEK | -0,09 | -0,04 | -0,11 | -0,16 |
| Equity per share, SEK | 1,83 | 1,99 | 1,93 | 1,83 |
| Number of shares (thousands) | 78 464 | 78 464 | 78 464 | 78 464 |
| Weighted avg. number of shares, adjusted for dilution | ||||
| effect (thousands) | 78 464 | 78 464 | 78 464 | 78 464 |
| Number of employees at the end of the period | 36 | 32 | 35 | 36 |
| Average number of employees during the period | 36 | 31 | 32 | 34 |
| Annual Recurring Revenue | 18 376 | 18 317 | 18 980 |
* The key indicator is calculated excluding current liabilities to EastCoast International AB.
| Amounts in SEK thousands | 2025 | 2024 | 2024 | Rolling |
|---|---|---|---|---|
| unless otherw ise stated | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Net sales | 20 007 | 21 684 | 86 852 | 85 175 |
| Net sales grow th, % | -7,7% | 13,2% | 15,7% | 9,8% |
| Gross profit | 14 392 | 15 657 | 63 066 | 61 801 |
| Net sales | 20 007 | 21 684 | 86 852 | 85 175 |
| Gross margin, % | 71,9% | 72,2% | 72,6% | 72,6% |
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 639 |
| Net sales | 20 007 | 21 684 | 86 852 | 85 175 |
| Operating margin, % | -35,2% | -13,0% | -10,8% | -16,0% |
| EBITDA | -1 689 | 3 069 | 13 379 | 8 622 |
| Depreciation and amortization | -5 362 | -5 895 | -22 794 | -22 260 |
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 638 |
| Current assets | 65 113 | 74 357 | 67 686 | 65 113 |
| Current liabilities excl. current liabilities EastCoast | ||||
| International* | 32 696 | 31 222 | 29 667 | 32 696 |
| Working capital | 32 417 | 43 135 | 38 019 | 32 417 |
| Sales expenses | -8 804 | -8 484 | -32 982 | -33 302 |
| Administrative expenses | -3 944 | -3 850 | -13 789 | -13 883 |
| R&D expenses | -7 097 | -6 808 | -26 966 | -27 255 |
| Other operating income/expenses | -1 597 | 658 | 1 256 | -999 |
| Total operating expenses | -21 441 | -18 483 | -72 480 | -75 438 |
| Cost of goods and services sold | -5 615 | -6 027 | -23 786 | -23 374 |
| Depreciation Cost of goods sold | 4 287 | 4 744 | 18 230 | 17 773 |
| Cost of goods and services sold excluding | ||||
| depreciation | -1 328 | -1 283 | -5 556 | -5 601 |
| Operating expenses | -21 441 | -18 483 | -72 480 | -75 438 |
| Depreciation Operating expenses | 1 075 | 1 152 | 4 564 | 4 487 |
| Operating costs excluding depreciation | -20 366 | -17 331 | -67 916 | -70 951 |
| Balance sheet total | 201 517 | 216 473 | 203 066 | 201 517 |
| Non-interest-bearing liabilities | 46 577 | 42 485 | 40 611 | 46 577 |
| Capital employed | 154 939 | 173 988 | 162 455 | 154 939 |
| 143 629 | 156 509 | 151 163 | 143 629 | |
| Closing equity | 149 480 | 163 176 | 152 700 | 149 480 |
| Average equity | ||||
| Current assets minus inventories | 64 891 | 74 065 | 67 445 | 64 891 |
| Current liabilities | 38 656 | 37 350 | 35 621 | 38 656 |
| Liquidity ratio, % | 168% | 198% | 189% | 168% |
| Equity | 143 629 | 156 509 | 151 163 | 143 629 |
| Total assets | 201 517 | 216 473 | 203 066 | 201 517 |
| Equity/assets ratio, % | 71,3% | 72,3% | 74,4% | 71,3% |
Interim Report Jan – Mar 2025
Precise Biometrics AB (publ), corp. ID no. 556545-6596
| 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jan-Mar | Jan-Mar | Full-year | 12 mth |
| Net sales | 2,3 | 20 007 | 21 684 | 86 852 | 85 175 |
| Cost of goods and services sold excluding depreciation | -1 328 | -1 284 | -5 556 | -5 600 | |
| Operating costs excluding depreciation | -23 329 | -20 305 | -78 883 | -81 907 | |
| Capitalized development expenses | 2 961 | 2 974 | 10 967 | 10 955 | |
| EBITDA | -1 689 | 3 069 | 13 379 | 8 621 | |
| Total depreciation excluding acquired immaterial assets | -4 761 | -5 290 | -20 362 | -19 833 | |
| Total depreciation acquired immaterial assets | -601 | -605 | -2 431 | -2 426 | |
| Operating profit/loss | -7 051 | -2 826 | -9 414 | -13 639 |
Interim Report Jan – Mar 2025
ARR is defined as repeat revenues at the end of the quarter for Digital Identity, converted to a 12-month period. Consequently, there is no direct link between the ARR figure and future software revenues for Digital Identity. The ARR metric is used for contractual recurring revenues for the Digital Identity segment, as Digital Identity has a large customer base based on SaaS revenues. There are a small number of large customers in Biometric Technologies, and therefore license fees are not followed up using the definition of ARR in this segment.
Gross profit/loss divided by net sales. Indicates the proportion of sales that is left over to cover wages, other operating expenses, interest and profit.
Profit/loss before financial items and depreciation. This key indicator shows the Group's profit/loss before depreciation/amortization of capitalized assets. This measure makes it possible to make comparisons with other companies, regardless of whether the operation is based on acquisitions or through organic growth.
Equity at the end of the period. Equity is the difference between the Group's assets and liabilities, which corresponds to the Group's equity that has been contributed by shareholders and the Group's accumulated profit.
Equity on the balance sheet date divided by the number of shares on the balance sheet date. A measure of the value of equity per share, which is used when valuing the share in relation to the share price.
The average equity was calculated as equity for the last four quarters divided by four.
Cash flow from operating activities after changes in working capital. The operating cash flow indicates whether a company can generate a sufficiently positive cash flow to maintain and expand its operation, or whether it needs external financing.
Current assets excluding inventories divided by current liabilities. This key figure shows the group's ability to pay in the short term.
Percentage change compared with the corresponding period in the previous year. A measure of whether a company's net sales are increasing.
Interim Report Jan – Mar 2025
Profit/loss for the period divided by weighted average number of shares.
Profit/loss for the period divided by average number of shares.
Profit/loss after tax divided by average equity. This key indicator shows the business's return on shareholders' capital invested and is thus a measure of how profitable the Group is. Investors can compare this measure with the current bank interest rate or return from alternative investments. The measure can also be used to compare profitability between companies in the same industry.
Current assets less current liabilities. This measure shows the capital a company needs to finance operating activities.
Operating expenses excluding cost of goods sold. Operating expenses are expenses that do not belong directly to a particular product or product group. Common operating expenses include, for example, wages and other personnel expenses, as well as rental of premises.
Operating profit/loss divided by net sales. Defines what proportion of each Swedish krona of sales is left over to cover interest, taxes and any possible profit.
Profit/loss before net financial items and tax. A measure of a company's profit before interest and taxes, i.e., the difference between operating income and operating expenses.
Equity divided by assets on the balance sheet date. This key indicator shows what proportion of assets is funded by equity. This measure can be of interest when assessing the Group's ability to pay in the long term.
Total assets less non-interest-bearing liabilities and provisions. This measure shows how much capital is used in operations and is thus one component of measuring the return from operations.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.